CARRI ROSS: Open Payments
NPI 1124009261 · VESTAL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$981 in 51 payments from 10 companies in 2025. Trend: 2023 $677 · 2024 $502 · 2025 $981
Food & beverage: $971Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $253 |
| ABBVIE INC. | 11 | $146 |
| Novartis Pharmaceuticals Corporation | 6 | $133 |
| Incyte Corporation | 6 | $129 |
| Lilly USA, LLC | 5 | $112 |
| GENZYME CORPORATION | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| PFIZER INC. | 3 | $53 |
| UCB, Inc. | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $15 |
Products named: TREMFYA, OPZELURA, SKYRIZI, DUPIXENT, TALTZ, COSENTYX, CIBINQO, Bimzelx.
Industry payments across NY — which companies pay providers there.
